27-Year Pharmaceutical Marketing Leader Ruth Desmond Join...(a more ideal candidate to lead our healt...),Health

Date:1/13/2009

a more ideal candidate to lead our healthcare initiatives. Ruth's endorsement by way of embracing and promoting our technology was the most flattering and humbling praise to receive; we couldn't be more excited about where her influence and reputation will take us now."

Dr. Desmond joins Stream57 as the company comes off a banner year. In 2008, Stream57 nearly doubled in size, executed first-time projects for several new industries such as publishing and consumer product marketing, and received multiple awards and accolades including a prize at the Medical Marketing & Media Awards.

"One of my favorite quotes is from the great philosopher, Wayne Gretzky. I think he also played a little hockey," Desmond joked. "He said, 'I skate to where the puck is going to be, not where it is.' Right now, the puck is blazing toward multi-channel marketing and nobody does it better than Stream57."

For interviews or additional information, please contact Andrew Parker at 212-909-2550 x1020 or aparker@s57.com.

About Stream57

Stream57 is an energetic team that believes in the power of the Internet for learning, marketing and entertainment, with offices in New York and London. StreamLine 2.9.5, Stream57's cutting-edge webcast and rich media software suite, brings a new level of interactivity to online video presentations and e-learning. Recently named #745 in the Inc. 5000 List of Fastest Growing Private Companies, Stream57 was founded in 2001 by President Ben Chodor, and has provided software and services for rich media delivery, webcasting and e-learning solutions for a wide range of distinguished clients, including several Fortune 1000 corporations, charities, B2B publishers, higher education institutions and healthcare organizations. For more information on Stream57, please call 21
'/>"/>

SOURCE Stream57 Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance